Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L0RK
|
||||
Former ID |
DNC006200
|
||||
Drug Name |
4-hydroxy-N-phenyl-N-propylbenzenesulfonamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527880] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H17NO3S
|
||||
Canonical SMILES |
CCCN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O
|
||||
InChI |
1S/C15H17NO3S/c1-2-12-16(13-6-4-3-5-7-13)20(18,19)15-10-8-14(17)9-11-15/h3-11,17H,2,12H2,1H3
|
||||
InChIKey |
VUUWGEGTDFUSTR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [527880] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.